Can BMS be salvaged?

[anonymous]

Before the Celgene deal, BMS had revenue. After rosy projections for success with Celgene, BMS didn't make revenue. It was a bad deal.
Questions?
Bristol Myers Squibb Revenue 2010-2024 | BMY

Amen. Cell therapy started as shit and is ending with shit.

 

[anonymous]

The new KarXT division will save BMS.

 

[anonymous]

The new KarXT division will save BMS.

It's going to be the final domino that topples the company IMO.

We overpaid for an asset that has generic competition on the near horizon. $15 billion isn't chump change.

KarXT acquisition is a poorly calculated gamble that has a high chance of failing, although we at least have a couple years until things really start to collapse internally. Do your own due diligence and drink the Kool-Aid at your own risk. Slurp Slurp.

 

[anonymous]

The new KarXT division will save BMS.

Oh man how many times have we heard this

"Sotyktu will save BMS"

"Zeposia will save BMS"

"Camzyos will save BMS"

"Abecma will save BMS"

etc.. etc... I can go on for days.

KarXT is the proverbial domino that is likely going to topple our company. $15 billion doesn't grow on trees and the margin for error gets thinner by the day.

 

[Morticia]

Lurch will save us.

 

[anonymous]

Oh man how many times have we heard this

"Sotyktu will save BMS"

"Zeposia will save BMS"

"Camzyos will save BMS"

"Abecma will save BMS"

etc.. etc... I can go on for days.

KarXT is the proverbial domino that is likely going to topple our company. $15 billion doesn't grow on trees and the margin for error gets thinner by the day.

I dont think you understand the talented leadership team that was put in place for KarXT.

 

[anonymous]

I dont think you understand the talented leadership team that was put in place for KarXT.

You are correct, I do however understand the talentless big pharma rejects that we’re hired. KarXT will be a colossal failure

 

[anonymous]

I dont think you understand the talented leadership team that was put in place for KarXT.

Thank you for that big laugh I needed.....

 

[anonymous]

Standing ovation.
Celgene was a one drug company. Celgene came in with no ethics and dominated the naive BMS people. Everyone and their mother in BMS were kissing up to Celgene instead of showing them their place. Happening now as we speak. Unethical org with no brains. That’s Celgene. BMS left its way of working to do all the wrong things the Celgene way. Look at the leftover Celgene. All tight knit and slowly removing BMS people maliciously. All leftover Celgene are unethical and do not follow any BMS regs or SOPs or practically anything. To this day, they don’t consider themselves part of BMS. Rotten bunch.

Clueless take. BMS ruined Celgene. All near team catalysts were Celgene. BMS brought nothing to the table. If Celgene been able to maintain its independence it would have been incredibly successful. The BMS culture is horrific and its lifers are bloated, inept managers who cannot make any decisions.

 

[anonymous]

Clueless take. BMS ruined Celgene. All near team catalysts were Celgene. BMS brought nothing to the table. If Celgene been able to maintain its independence it would have been incredibly successful. The BMS culture is horrific and its lifers are bloated, inept managers who cannot make any decisions.

This is the same story for every biotech who got bought out by a big pharma in the last decade or 2. The original biotech leadership from the late 90's and even early 2000's tended to be much more entrepreneurial and clinical. Those guys got the giant stock payouts and left when their companies got bought out. They have been replaced by the usual suspects from the big pharma. These clueless guys just recycle everything they learned from McKinsey and the likes. The results are highly predictable and history simply keeps repeating itself. Anything that big pharma touches turns to you know what. Same old story. Different day.

 

[anonymous]

Clueless take. BMS ruined Celgene. All near team catalysts were Celgene. BMS brought nothing to the table. If Celgene been able to maintain its independence it would have been incredibly successful. The BMS culture is horrific and its lifers are bloated, inept managers who cannot make any decisions.

The efficacy and safety of the drugs speak for themselves. Show me a drug after Rev, the drugs that BMS invested in with the 70b acquisition. Failed drugs and Delayed launches due to failed Celgene designed trials which were rejected by the FDA. BMS ruined everything by not only keeping tons of ex Celgene but promoting them multiple times. BMS did not show leadership or knowledge and you are seeing the results in massive layoffs.

 

[anonymous]

The efficacy and safety of the drugs speak for themselves. Show me a drug after Rev, the drugs that BMS invested in with the 70b acquisition. Failed drugs and Delayed launches due to failed Celgene designed trials which were rejected by the FDA. BMS ruined everything by not only keeping tons of ex Celgene but promoting them multiple times. BMS did not show leadership or knowledge and you are seeing the results in massive layoffs.

BMS and its people are dog sh!t. Stop trying to assign blame, we all know BMS is filled with the dregs of humanity